GM Breweries Q2 FY27: Shares fall 6.6% as margins contract 250 bps
Synopsis
GM Breweries posted double-digit profit and revenue growth in Q2 FY27 — and still saw its shares tank nearly 7%. The culprit: EBITDA margins compressed by more than 250 basis points to 23.5%, a warning sign for a stock already down 25% from its 52-week high. In India's regulated country liquor space, margin erosion can persist, and the market voted with a selloff.
Key Takeaways
GM Breweries shares fell as much as 6.61 per cent to ₹921 on the BSE on 8 October 2026 after Q2 FY27 results.
Net profit rose 12.3 per cent YoY to ₹39.3 crore ; revenue grew 18.2 per cent to ₹214 crore .
EBITDA margin contracted over 250 basis points to 23.5 per cent from 25 per cent in Q2 FY26, triggering the selloff.
The stock was already down about 25 per cent from its 52-week high of ₹1,328.80 and 22 per cent year-to-date before Thursday's session.
In Q1 FY27 , the company had reported a 46 per cent YoY profit surge — a high base making Q2 growth appear comparatively modest.
Shares of GM Breweries Limited tumbled as much as 6.61 per cent to an intra-day low of ₹921 on the BSE on Thursday, 8 October 2026, after the country liquor maker reported its Q2 FY27 results that revealed a meaningful contraction in operating margins, even as headline profit and revenue numbers moved higher. The sharp reversal — the stock had gained up to 2 per cent earlier in the session — underscored how closely investors are watching profitability quality, not just topline growth.
Q2 FY27 Financial Highlights
Net profit rose 12.3 per cent year-on-year to ₹39.3 crore in the quarter ended September 2026, compared with ₹35 crore in the same period last year. Revenue from operations climbed 18.2 per cent to ₹214 crore from ₹181 crore a year earlier. EBITDA grew 12 per cent to ₹50.3 crore versus ₹45 crore in the year-ago quarter.
The Margin Concern Spooking Investors
Despite the year-on-year improvement in absolute numbers, EBITDA margin contracted to 23.5 per cent from 25 per cent in Q2 FY26 — a compression of more than 250 basis points. This margin deterioration appears to have overshadowed the otherwise positive revenue and profit trajectory, triggering the selloff. Sequentially, profit edged up from ₹38 crore in Q1 FY27, and revenue rose from ₹200 crore in the June quarter, suggesting some quarter-on-quarter momentum, but not enough to offset concerns about cost pressures eating into profitability.
About GM Breweries and Its Portfolio
GM Breweries is a prominent player in India's country liquor market, with brands including Santra, G.M. Doctor, and G.M. Limbu Punch in its portfolio. The company primarily caters to the mass-market segment, where price sensitivity and input cost dynamics can meaningfully affect margins. This is a segment that tends to face pressure when raw material or distribution costs rise faster than permissible retail prices, which are often regulated at the state level.
Stock Performance Context
Thursday's decline adds to an already significant correction in the stock. Before this session, GM Breweries shares had fallen approximately 25 per cent from their 52-week high of ₹1,328.80 and were down roughly 22 per cent year-to-date. Notably, this comes after a comparatively strong Q1 FY27, when the company had posted a 46 per cent year-on-year surge in net profit and a 23 per cent rise in revenue — a high base that may also be making the latest quarter's growth rate look more modest in comparison.
What to Watch Next
Analysts and investors will be closely monitoring whether the margin compression in Q2 reflects a structural cost-push or a transient blip. Management commentary on input costs, state-regulated pricing, and volume outlook for the second half of FY27 will be key. If margins do not recover in Q3 FY27, the stock's descent from its 52-week high could deepen further.
Point of View
The quality of earnings matters more than the headline number. A 12 per cent profit rise would ordinarily be welcomed — but a 250-basis-point margin contraction in a state-regulated, input-cost-sensitive business signals that growth is coming at a price. The stock's year-to-date underperformance suggests the market had already been pricing in deteriorating fundamentals; Thursday's results confirmed those fears. Unless management provides credible guidance on margin recovery, the stock's path back to its 52-week high looks distant.
NationPress
8 Oct 2026
Frequently Asked Questions
Why did GM Breweries shares fall today?
GM Breweries shares fell as much as 6.61 per cent to ₹921 on the BSE on 8 October 2026 after the company's Q2 FY27 results showed EBITDA margin contracting by more than 250 basis points to 23.5 per cent, despite growth in net profit and revenue. Investors reacted negatively to the margin squeeze, reversing an earlier 2 per cent gain in the session.
What were GM Breweries' Q2 FY27 financial results?
For the quarter ended September 2026, GM Breweries reported a 12.3 per cent year-on-year increase in net profit to ₹39.3 crore and an 18.2 per cent rise in revenue to ₹214 crore. EBITDA grew 12 per cent to ₹50.3 crore, but EBITDA margin fell to 23.5 per cent from 25 per cent a year earlier.
How has GM Breweries stock performed this year?
Before Thursday's session, GM Breweries shares had already fallen approximately 25 per cent from their 52-week high of ₹1,328.80 and were down about 22 per cent year-to-date. The Q2 FY27 margin miss added further pressure to an already-correcting stock.
What brands does GM Breweries sell?
GM Breweries is a prominent player in India's country liquor market, with a portfolio that includes brands such as Santra, G.M. Doctor, and G.M. Limbu Punch. The company primarily serves the mass-market segment, where margins are sensitive to input costs and state-regulated pricing.
How does Q2 FY27 compare to Q1 FY27 for GM Breweries?
Q2 FY27 showed more modest growth compared to Q1 FY27, when GM Breweries had reported a 46 per cent year-on-year surge in net profit and a 23 per cent rise in revenue. Sequentially, Q2 profit rose marginally from ₹38 crore and revenue from ₹200 crore in Q1 FY27.
